Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clary, B. M.
Right arrow Articles by Brennan, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clary, B. M.
Right arrow Articles by Brennan, M. F.
Related Collections
Right arrow Prognostic factors
Right arrow Surgery
Annals of Surgical Oncology 8:290-299 (2001)
© 2001 Society of Surgical Oncology


ORIGINAL ARTICLES

Gastrointestinal Stromal Tumors and Leiomyosarcoma of the Abdomen and Retroperitoneum: A Clinical Comparison

Bryan M. Clary, MD, Ronald P. DeMatteo, MD, Jonathan J. Lewis, MD, Denis Leung, PhD and Murray F. Brennan, MD

From the Departments of Surgery (BMC, RPD, JJL, MFB) and Biostatistics (DL), Memorial Sloan-Kettering Cancer Center, New York, New York.

Correspondence: Address correspondence and reprint requests to: Dr. Murray F. Brennan, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021; Fax: 212-794-3184; E-mail: brennanm{at}mskcc.org

Introduction: The present study was undertaken to define the clinical differences between leiomyosarcomas (LMS) occurring within the abdomen and retroperitoneum and gastrointestinal stromal tumors (GIST).

Methods: It was a retrospective, single-institution review of patients treated for intra-abdominal and retroperitoneal GIST and LMS from July 1, 1982 through August 1, 1999.

Results: A total of 561 patients, 239 with GIST and 322 with LMS, were identified. Patients with GIST were older, with a median age of 58 years versus 54 years in the LMS group (P < .01). The majority of patients with GIST were male (58%), whereas 68% of LMS patients (excluding gender-specific sites) were female (P < .01). The 5-year disease-specific survival for GIST and LMS were 28% and 29%, respectively. The presentation status and ability to achieve a complete surgical resection were the main independent predictors of outcome for both GIST and LMS. Local and distant recurrence was common in both. The pattern of distant recurrence differed: 50% of all first-site GIST recurrences involved the liver, whereas 30% of all LMS first-site recurrences involved the lungs.

Conclusions: Although the two patient populations appear to be distinct, their clinical courses are similar. The pattern of distant spread follows the known patterns of hematogenous dissemination. Complete surgical resection is the cornerstone of treatment for primary GIST and LMS and in selected patients with local and distant recurrence.

Key Words: Gastrointestincal stromal tumor • Leiomyosarcoma—Retroperitoneal Sarcoma




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
P. Rutkowski, Z. I. Nowecki, W. Michej, M. Debiec-Rychter, A. Wozniak, J. Limon, J. Siedlecki, U. Grzesiakowska, M. Kakol, C. Osuch, et al.
Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor
Ann. Surg. Oncol., July 1, 2007; 14(7): 2018 - 2027.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. A. Perez, J. C. Gutierrez, F. L. Moffat Jr, D. Franceschi, A. S. Livingstone, S. A. Spector, J. U. Levi, D. Sleeman, and L. G. Koniaris
Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location
Ann. Surg. Oncol., March 1, 2007; 14(3): 1114 - 1122.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. D. Price, J. Trent, A. K. El-Naggar, D. Cogdell, E. Taylor, K. K. Hunt, R. E. Pollock, L. Hood, I. Shmulevich, and W. Zhang
Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas
PNAS, February 27, 2007; 104(9): 3414 - 3419.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. H. I. Andtbacka, C. S. Ng, C. L. Scaife, J. N. Cormier, K. K. Hunt, P. W. T. Pisters, R. E. Pollock, R. S. Benjamin, M. A. Burgess, L. L. Chen, et al.
Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib
Ann. Surg. Oncol., January 1, 2007; 14(1): 14 - 24.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
S. L. Blair, W. B. Al-Refaie, J. Wang-Rodriguez, C. Behling, M.-W. Ali, and A. R. Moossa
Gastrointestinal Stromal Tumors Express ras Oncogene: A Potential Role for Diagnosis and Treatment
Arch Surg, June 1, 2005; 140(6): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Sandrasegaran, A. Rajesh, J. Rydberg, D. A. Rushing, F. M. Akisik, and J. D. Henley
Gastrointestinal Stromal Tumors: Clinical, Radiologic, and Pathologic Features
Am. J. Roentgenol., March 1, 2005; 184(3): 803 - 811.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. T. Betts, E. J. Huo, and F. H. Miller
Gastrointestinal and Genitourinary Smooth-Muscle Tumors
Am. J. Roentgenol., November 1, 2003; 181(5): 1349 - 1354.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Pollock
Soft Tissue Sarcoma: Setting the Stage
Ann. Surg. Oncol., May 1, 2001; 8(4): 273 - 274.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society of Surgical Oncology.